Number Needed to Treat (NNT) and Number Needed to Harm (NNH) in Randomized, Blinded Trials Comparing Olanzapine to Other Atypical Antipsychotics for Treatment of Schizophrenia-Reference-Cited by-同舟云学术

Number Needed to Treat (NNT) and Number Needed to Harm (NNH) in Randomized, Blinded Trials Comparing Olanzapine to Other Atypical Antipsychotics for Treatment of Schizophrenia

Published:2008-07 Issue:2 Volume:2 Page:136-146
ISSN:1935-1232
Container-title:Clinical Schizophrenia & Related Psychoses
language:en
Short-container-title:Clinical Schizophrenia & Related Psychoses

Author:

Stauffer Virginia,Karagianis Jamie,Sutton Virginia,Ascher-Svanum Haya,Treuer Tamas,de Lima Mauricio,Ball Tamara,Poole-Hoffmann Vicki,Tohen Mauricio

Publisher

Longdom Group

Subject

Psychiatry and Mental health,General Medicine

Reference32 articles.

1. All-Cause Treatment Discontinuation in Schizophrenia During Treatment With Olanzapine Relative to Other Antipsychotics

2. Longer Time to Antipsychotic Treatment Discontinuation for Any Cause Is Associated With Better Functional Outcomes for Patients With Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder

3. Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs

4. Intermittent vs Maintenance Medication in Schizophrenia

5. Adherence to Treatment With Antipsychotic Medication and Health Care Costs Among Medicaid Beneficiaries With Schizophrenia

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The New Horizon of Antipsychotics beyond the Classic Dopaminergic Hypothesis—The Case of the Xanomeline–Trospium Combination: A Systematic Review;Pharmaceuticals;2024-05-09

2. Number Needed to Treat or Harm Analyses of Olanzapine for Maintenance Treatment of Bipolar Disorder;Journal of Clinical Psychopharmacology;2009-12

3. Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations;European Archives of Psychiatry and Clinical Neuroscience;2009-10-17

4. Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials;BMC Psychiatry;2009-03-31